Volume 13, Number 4—April 2007
Hantavirus and Arenavirus Antibodies in Persons with Occupational Rodent Exposure, North America
Rodents are the principal hosts of Sin Nombre virus, 4 other hantaviruses known to cause hantavirus pulmonary syndrome in North America, and the 3 North American arenaviruses. Serum samples from 757 persons who had worked with rodents in North America and handled neotomine or sigmodontine rodents were tested for antibodies against Sin Nombre virus, Whitewater Arroyo virus, Guanarito virus, and lymphocytic choriomeningitis virus. Antibodies against Sin Nombre virus were found in 4 persons, against Whitewater Arroyo virus or Guanarito virus in 2 persons, and against lymphocytic choriomeningitis virus in none. These results suggest that risk for infection with hantaviruses or arenaviruses usually is low in persons whose occupations entail close physical contact with neotomine or sigmodontine rodents in North America.
Hantavirus pulmonary syndrome (HPS) is a frequently fatal rodentborne viral zoonosis. Seven species in the virus family Bunyaviridae, genus Hantavirus (1), have been causally associated with HPS: Sin Nombre virus (SNV), New York virus (NYV), Black Creek Canal virus (BCCV), Bayou virus (BAYV), and Choclo virus (CHOV) in North America (2–6), and Andes virus (ANDV) and Laguna Negra virus (LANV) in South America (7,8).
The virus family Arenaviridae, genus Arenavirus, includes 3 North American species and 14 South American species (9). The North American species are Bear Canyon virus (BCNV), Tamiami virus (TAMV), and Whitewater Arroyo virus (WWAV). The South American species include Guanarito virus (GTOV), Junin virus (JUNV), Machupo virus (MACV), and Sabiá virus (SABV). These 4 South American species have been causally associated with severe human disease in Venezuela, Argentina, Bolivia, and Brazil, respectively (10). The human health importance of the North American arenavirus species has not been rigorously investigated.
Specific members of the subfamilies Neotominae and Sigmodontinae in the rodent family Cricetidae (11) are the principal hosts (reservoirs) of the hantaviruses known to cause HPS in North America and the 3 North American arenaviruses. For example, principal hosts and their respective viruses include: the deer mouse (Peromyscus maniculatus) in Canada and the western United States, SNV (12,13); the white-footed mouse (Peromyscus leucopus) in the northeastern United States, NYV (3); the hispid cotton rat (Sigmodon hispidus) in Florida, BCCV and TAMV (4,14); the marsh rice rat (Oryzomys palustris) in the southeastern United States, BAYV (15–17); the fulvous colilargo (Oligoryzomys fulvescens) in Panama, CHOV (6); the California mouse (Peromyscus californicus) in California, BCNV (18); and the white-throated woodrat (Neotoma albigula) in New Mexico, WWAV (19). P. maniculatus, P. leucopus, P. californicus, and N. albigula are members of the Neotominae and S. hispidus, O. palustris, and O. fulvescens are members of the Sigmodontinae (11).
It is assumed that humans usually become infected with hantaviruses and arenaviruses by inhalation of aerosolized droplets of urine, saliva, or respiratory secretions from infected rodents. Other means of infection include, but are not limited to, inhalation of dust or other organic matter contaminated with infectious virus and contact of infectious materials with mucous membranes.
The purpose of this study was to assess the risk for hantavirus and arenavirus infections among persons who work in North America and have close physical contact with neotomine rodents or sigmodontine rodents through their occupations. These persons include mammalogists, wildlife biologists, scientists whose research concerns the ecology of rodent-borne zoonoses, and pest control operators.
The persons in this study were participants in a survey conducted in 1994 by the Centers for Disease Control and Prevention (CDC). The primary objective of the survey was to assess the risk for hantavirus infections in persons whose occupations expose them to rodents. Participation in the survey was voluntary and entailed completion of a self-administered questionnaire and donation of a small volume of venous blood. Most of the 995 participants were enrolled at 1 of the following: American Society of Mammalogists meeting (Washington, DC, 1994), Wildlife Disease Association meeting (Pacific Grove, California, 1994), Southwestern Association of Naturalists meeting (Emporia, Kansas, 1994), Wildlife Society meeting (Wenatchee, Washington, 1994), 16th Vertebrate Pest Conference (Santa Clara, California, 1994), and Colorado Pest Control Meeting (Denver, Colorado, 1994). The other participants mailed their completed questionnaires and serum samples directly to CDC.
The questionnaire included detailed questions about previous exposure to rodents, use of personal protective equipment to minimize exposure to rodent excretions and secretions, and any previous occurrence of a severe febrile illness that included shortness of breath. The lifetime number of rodents handled by a person was measured categorically: I (1–99), II (100–499), III (500–999), IV (1,000–9,999), V (10,000–49,999), and VI (≥50,000). Use of gloves, protective masks equipped with high efficiency particulate air (HEPA) filters, and protective eyewear also was measured categorically: always (>90% of the time), usually (50%–90% of the time), sometimes (10%–49% of the time), seldom (<10% of the time), or never.
This study was restricted to the 757 participants in the CDC survey who had a history of exposure to rodents in North America and a history of occupational exposure to deer mice, white-footed mice, California mice, woodrats (Neotoma spp.), other neotomine rodents, cotton rats (Sigmodon spp.), oryzomyine rodents (Oryzomys spp. or Oligoryzomys spp.), or other sigmodontine rodents. Of the persons included in the study, 699 had worked with rodents only in North America. The 58 others had worked with rodents in North America and in South America. The geographic distribution of exposure to rodents in North America was Canada (n = 36), Alaska (n = 8), the contiguous United States or District of Columbia (n = 726, Table 1), Mexico (n = 91), Guatemala (n = 8), Belize (n = 3), Honduras (n = 3), Costa Rica (n = 21), Nicaragua (n = 4), and Panama (n = 8). Of the persons included in the study, 468 (61.8%) had worked with rodents in >1 state within the contiguous United States.
Persons included in the study had worked with rodents from 1 month to 65 years (mean 12.5 years). The total number of rodents handled by any 1 person ranged from category I (1–99) to category VI (≥50,000); the median was IV (1,000–9,999). Of the 757 persons in the study, 751 (99.2%) had handled deer mice, white-footed mice, cotton rats, oryzomymine rodents, California mice, or woodrats (Table 2).
HPS was first recognized as a clinical entity in 1993 in the southwestern United States (20). From March 1, 1993, through September 19, 2006, a total of 453 laboratory-confirmed HPS cases were reported to CDC from the contiguous United States (www.cdc.gov/ncidod/diseases/hanta/hps/noframes/epislides/episl7.htm). Of these, 259 (57.2%) were reported from 6 states in the southwestern United States: Colorado (n = 51), New Mexico (n = 71), Utah (n = 25), Arizona (n = 49), Nevada (n = 18), and California (n = 45). Sin Nombre virus is the only virus known to cause HPS in these 6 states. In this study, 387 (51.1%) persons had worked with rodents in Colorado (n = 124), New Mexico (n = 111), Utah (n = 65), Arizona (n = 90), Nevada (n = 33), or California (n = 169) and had handled deer mice. The total number of deer mice handled by persons in this group ranged from I (1–99) to VI (≥50,000); the median was II (100–499).
The geographic range of BAYV includes Georgia, Louisiana, and Texas (5,15–17), BCCV has been found only in Florida (4), and the geographic range of NYV includes New York, Pennsylvania, and Rhode Island (3,21,22). In this study, 22 persons had worked with rodents in Georgia (n = 1), Louisiana (n = 2), or Texas (n = 20) and handled oryzomyine rodents. The total number of oryzomyine rodents handled by persons in this group ranged from I (1–99) to IV (1,000–9,999); the median was I (1–99). Fourteen persons had worked with rodents in Florida and handled cotton rats. The total number of cotton rats handled by persons in this group ranged from I (1–99) to IV (1,000–9,999); the median was II (100–499). Eighty-one persons had worked with rodents in New York (n = 45), Pennsylvania (n = 42), or Rhode Island (n = 5) and handled white-footed mice. The total number of white-footed mice handled by persons in this group ranged from I (1–99) to V (10,000–49,999); the median was II (100–499).
BCNV virus has been found only in California (18) and TAMV only in Florida (14); the geographic range of WWAV and other arenaviruses naturally associated with woodrats (Neotoma spp.) includes Arizona, California, Colorado, New Mexico, Oklahoma, Utah, and Texas (19,23–27). In this study, 31 persons had worked with rodents in California and handled California mice (P. californicus). The total number of California mice handled by persons in this group ranged from I (1–99) to III (500–999); the median was I (1–99). As indicated previously, 14 persons had worked with rodents in Florida and handled cotton rats. Three hundred and thirty-three persons had worked with rodents in Arizona (n = 87), California (n = 130), Colorado (n = 76), New Mexico (n = 101), Oklahoma (n = 40), Utah (n = 59), or Texas (n = 101) and handled woodrats. The total number of woodrats handled by persons in this group ranged from I (1–99) to V (10,000–49,999); the median was I (1–99).
Lymphocytic choriomeningitis virus (LCMV) is the only Old World arenavirus species that is enzootic in North America. The house mouse (Mus musculus) is a member of the subfamily Murinae, family Muridae (11) and the principal host of LCMV. In this study, 526 (69.5%) persons had worked with house mice. The total number of house mice handled by persons in this group ranged from I (1–99) to VI (>50,000); the median was I (1–99).
Of the 757 persons in this study, 735 (97.1%) had worked with rodents before the discovery of HPS in 1993; during that time, 504 (68.6%) of them never or infrequently wore personal protective equipment (gloves, a protective mask equipped with HEPA filters, and protective eyewear) when handling rodents. In contrast, only 267 (36.3%) of these 735 persons never or infrequently wore personal protective equipment when handling rodents after the discovery of HPS. Use of personal protective equipment by the other persons in the study both before and after the discovery of HPS depended on the type of equipment.
All unique identifying information was removed from the serum samples before they were tested for antibodies. Furthermore, all unique identifying information was removed from the computer (electronic) records before analysis of the demographic and serologic data.
We tested the serum samples for immunoglobulin G (IgG) against SNV, WWAV, GTOV, and LCMV by using ELISA, as described (24,28). The SNV antigen was an Escherichia coli–expressed recombinant SNV nucleocapsid protein that is highly cross-reactive with other neotomine rodent-associated hantaviruses and with sigmodontine rodent-associated hantaviruses in the ELISA used in this study (T.G. Ksiazek, unpub. data). The control (comparison) antigen for the SNV IgG ELISA was an E. coli–expressed recombinant protein that is antigenically unrelated to the SNV nucleocapsid protein. The arenavirus antigens were detergent lysates of Vero E6 cells infected with WWAV strain AV 9310135, GTOV strain INH-95551, or LCMV strain Armstrong. WWAV is highly cross-reactive with BCNV and TAMV in the ELISA used in this study (M.L. Milazzo, unpub. data). Collectively, WWAV, GTOV, and LCMV represent the 3 major antigen groups in the family Arenaviridae, as defined by ELISA (19). The control antigens for the arenavirus IgG assays were detergent lysates of uninfected Vero E6 cells. The working concentrations of the SNV, GTOV, and LCMV antigens and the corresponding control antigens were determined by checkerboard titration against convalescent-phase serum samples from humans infected with SNV, GTOV, and LCMV, respectively. The working concentrations of the WWAV antigen and the corresponding control antigen were determined by checkerboard titration against a mouse ascitic fluid against WWAV strain AV 9310135. Serial 4-fold dilutions (from 1:100 through 1:6,400) of each serum sample were tested against the 4 test antigens and 4 control antigens. Antibody bound to antigen was detected by using a goat anti-human IgG (gamma chain–specific) peroxidase conjugate (Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA). Optical densities (OD) at 405 nm (reference = 490 nm) were measured with a Dynex MRX II microplate reader (Dynatech Industries, Inc., McLean, VA, USA). The adjusted OD (AOD) of a serum-antigen reaction was the OD of the well coated with the test antigen minus the OD of the well coated with the control antigen. A sample was considered positive if the AOD at 1:100 was ≥0.200, the AOD at 1:400 was ≥0.200, and the sum of the AODs for the series of 4-fold dilutions (from 1:100 through 1:6,400) was ≥0.900. These criteria for positivity were based on the results of previous work with the test antigens and control antigens. The antibody titer of a positive sample was the reciprocal of the highest dilution of that sample for which the AOD was ≥0.200.
Antibodies against SNV were detected in 4 (0.5%) of the 757 persons in the study. Antibody titers were 1,600 in 2 persons and ≥6,400 in the other 2 persons. The total years worked with rodents and the lifetime number of rodents handled by the 4 antibody-positive persons were 9.0–30.0 (mean 21.3) and IV (1,000–9,999) to V (10,000–49,999), respectively. Two of the antibody-positive persons had worked with rodents only within the contiguous United States (specifically Arkansas, Arizona, Colorado, Iowa, Kansas, Michigan, Oklahoma, South Carolina, and/or Texas), 1 had worked with rodents in Arizona, Colorado, New Mexico, Utah, Texas, and Mexico, and 1 had worked with rodents in Michigan, Pennsylvania, Mexico, Costa Rica, and Argentina. All 4 antibody-positive persons had handled deer mice, white-footed mice, other neotomine rodents, cotton rats, and other sigmodontine rodents. Those who had worked in South Carolina or Argentina also had handled oryzomyine rodents. All 4 antibody-positive persons reported that they had never worn a protective mask or protective eyewear when handling rodents before the discovery of HPS. One reported having been hospitalized for an illness characterized by fever, headache, and severe shortness of breath (symptoms suggestive of HPS). This person had worked with rodents only within the contiguous United States.
Antibodies against WWAV or GTOV were detected in 2 (0.3%) of the 757 persons in the study. Antibodies against WWAV (antibody titer = 1,600) but not GTOV were detected in a person who had worked with rodents in Texas and Wisconsin and handled woodrats, other neotomine rodents, and sigmodontine rodents. Antibodies against GTOV (antibody titer = 1,600) but not WWAV were detected in a person who had worked with rodents in Pennsylvania, Utah, and Wyoming and handled white-footed mice, other neotomine rodents, cotton rats, and other sigmodontine rodents. The lifetime number of rodents handled by the 2 antibody-positive persons were III (500–999) and IV (1,000–9,999), respectively. Both reported that they had never worn a protective mask or protective eyewear when handling rodents before the discovery of HPS. Antibodies against LCMV were found in none of the 757 persons in this study.
Previously published studies found no antibodies against SNV in 583 persons who worked in Arizona or New Mexico in occupations that potentially exposed them to rodents or rodent droppings (29,30) and no antibodies against SNV or WWAV in 72 persons in California whose occupations entailed close physical contact with rodents (31). Limited seroprevalence studies found antibodies against LCMV in up to 5.1% of healthy persons in the United States (32,33). If one discounts fatal infections and assumes that IgG against SNV and other hantaviruses is measurable many years after recovery from infection, the results of this study indicate that the risk for infection with hantaviruses usually is low in persons whose occupations entail close physical contact with neotomine rodents or sigmodontine rodents in North America. Similarly, the study results indicate that the risk for infection with arenaviruses usually is low in persons whose occupations entail close physical contact with neotomine rodents or sigmodontine rodents in North America
Some hantaviruses and arenaviruses appear to be restricted to small areas within the geographic ranges of the rodent species that serve as their natural reservoirs. For example, BCCV and TAMV have been found only in southern Florida (4,14), yet the geographic range of S. hispidus extends from Arizona, Nebraska, and Virginia through northeastern Mexico (11). Furthermore, the prevalence of infected rodents can vary widely even in a small area (23,34). Thus, the low prevalence of antibodies against SNV and against the arenaviruses included in this study could be because few of the rodents handled by the 757 persons in the study were infected with a hantavirus or arenavirus. Other explanations for the low prevalence of antibodies against SNV, WWAV, GTOV, and LCMV in this study are because the circumstances under which or the manner in which the rodents were handled did not favor rodent-to-human virus transmission or because tissues, secretions, and excretions from infected rodents are not highly infectious to humans.
Antibodies against SNV were detected in 3 (0.8%) of the 387 persons in this study who had worked with rodents in Colorado, New Mexico, Utah, Arizona, Nevada, or California and who had handled deer mice. Antibodies to SNV also were detected in 1 (1.2%) of the 81 persons who had worked in New York, Pennsylvania, or Rhode Island and who had handled white-footed mice. The antibodies against SNV in the 3 antibody-positive persons who had worked in the southwestern United States could be a consequence of infection with SNV. The antibodies against SNV in the person who had worked in Pennsylvania could be a result of infection with NYV.
Of the 453 laboratory-confirmed HPS cases mentioned previously, 160 (35.3%) were fatal. Together, the high case-fatality ratio of HPS in North America, the lack of a vaccine against HPS, and the lack of a specific therapy for HPS should motivate persons to minimize their risk for infection while working in the field, classroom, or laboratory with rodents potentially infected with hantaviruses, especially those viruses known to cause HPS. Published guidelines for safely working with rodents potentially infected with hantaviruses include using protective gloves, respirators fitted with HEPA filters, and protective eyewear (35). None of the 4 persons in the study who were antibody-positive against SNV had worn gloves, masks, or protective eyewear when handling rodents before the discovery of HPS.
The use of personal protective equipment in the field may seem cumbersome. However, 2 recent HPS cases, 1 fatal, underscore the need to use appropriate personal protective equipment and follow recommended safety procedures when working with rodents potentially infected with hantaviruses that have been causally associated with HPS. The fatal case was in a graduate student who was studying the effects of forest management practices on small mammal populations in West Virginia (36). The nonfatal case was in a field technician who was trapping rodents as part of a forest health study in California (37). HPS has been reported in other persons whose occupations entailed close physical contact with wild rodents (38,39).
The person in this study who was antibody-positive against WWAV had worked with rodents in Texas and handled woodrats. Antibodies against WWAV strain AV 9310135 have been found in southern plains woodrats (Neotoma micropus) captured in western Texas and in northern Texas (M.L. Milazzo, unpub. data), and arenaviruses antigenically closely related to WWAV strain AV 9310135 have been isolated from southern plains woodrats captured in southern Texas (27,40). Thus, the antibodies against WWAV in this person could be a result of an arenavirus infection acquired from a woodrat captured in Texas.
When examined by antibody-antigen binding assays such as the ELISA, GTOV is distinct from the 3 North American arenaviruses and highly cross-reactive with JUNV, MACV, and SABV (19). Thus, the antibodies against GTOV in the person in this study could be a result of an arenavirus infection acquired while traveling in South America. Alternatively, the antibodies could be a result of infection with a North American arenavirus that is antigenically more closely related to GTOV than to BCNV, TAMV, or WWAV.
Recently, antibodies against GTOV but not WWAV or LCMV were detected in 3 peromyscine rodents (Peromyscus species) captured in southern Mexico (M.L. Milazzo, unpub. data). The antibodies against GTOV in these 3 rodents are the first evidence that an arenavirus antigenically distinct from BCNV, TAMV, WWAV, and LCMV exists in North America and support the idea that the infection in the antibody-positive person in this study was a result of an arenavirus infection acquired in North America.
Dr Fulhorst is an associate professor at University of Texas Medical Branch. His research interests include the epidemiology and ecology of rodentborne hantaviruses and arenaviruses native to the Americas.
National Institutes of Health grant AI-41435 provided financial support for the portion of this study conducted by M.L.M. and C.F.F.
This study was approved by the Committee for the Protection of Human Subjects, Centers for Disease Control and Prevention. Written informed consent was obtained from all participants in accordance with Title 45, Part 46 of the Code of Federal Regulations.
- Nichol ST, Beaty BJ, Elliott RM, Goldbach R, Plyusnin A, Schmaljohn CS, Family Bunyaviridae. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, editors. Virus taxonomy: eighth report of the International Committee on Taxonomy of Viruses. San Diego: Elsevier Academic Press; 2005. p. 695–711.
- Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science. 1993;262:914–7.
- Hjelle B, Lee SW, Song W, Torrez-Martinez N, Song JW, Yanagihara R, Molecular linkage of hantavirus pulmonary syndrome to the white-footed mouse, Peromyscus leucopus: genetic characterization of the M genome of New York virus. J Virol. 1995;69:8137–41.
- Khan AS, Gaviria M, Rollin PE, Hlady WG, Ksiazek TG, Armstrong LR, Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. Am J Med. 1996;100:46–8.
- Morzunov SP, Feldmann H, Spiropoulou CF, Semenova VA, Rollin PE, Ksiazek TG, A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana. J Virol. 1995;69:1980–3.
- Vincent MJ, Quiroz E, Gracia F, Sanchez AJ, Ksiazek TG, Kitsutani PT, Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology. 2000;277:14–9.
- López N, Padula P, Rossi C, Lázaro ME, Franze-Fernández MT. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology. 1996;220:223–6.
- Johnson AM, Bowen MD, Ksiazek TG, Williams RJ, Bryan RT, Mills JN, Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology. 1997;238:115–27.
- Salvato MS, Clegg JCS, Buchmeier MJ, Charrel RN, Gonzalez JP, Lukashevich IS, 2005. Family Arenaviridae. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, editors. Virus taxonomy: eighth report of the International Committee on Taxonomy of Viruses. San Diego: Elsevier Academic Press; 2005. p. 725–33.
- Peters CJ. Human infection with arenaviruses in the Americas. Curr Top Microbiol Immunol. 2002;262:65–74.
- Wilson DE, Reeder DM. Mammal species of the world. A taxonomic and geographic reference. 3rd edition. Baltimore: Johns Hopkins University Press; 2005.
- Drebot MA, Gavrilovskaya I, Mackow ER, Chen Z, Lindsay R, Sanchez AJ, Genetic and serotypic characterization of Sin Nombre-like viruses in Canadian Peromyscus maniculatus mice. Virus Res. 2001;75:75–86.
- Childs JE, Ksiazek TG, Spiropoulou CF, Krebs JW, Morzunov S, Maupin GO, Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis. 1994;169:1271–80.
- Jennings WL, Lewis AL, Sather GE, Pierce LV, Bond JO. Tamiami virus in the Tampa Bay area. Am J Trop Med Hyg. 1970;19:527–36.
- Ksiazek TG, Nichol ST, Mills JN, Groves MG, Wozniak A, McAdams S, Isolation, genetic diversity, and geographic distribution of Bayou virus (Bunyaviridae: hantavirus). Am J Trop Med Hyg. 1997;57:445–8.
- Torrez-Martinez N, Hjelle B. Enzootic of Bayou hantavirus in rice rats (Oryzomys palustris) in 1983. Lancet. 1995;346:780–1.
- Torrez-Martinez N, Bharadwaj M, Goade D, Delury J, Moran P, Hicks B, Bayou virus–associated hantavirus pulmonary syndrome in eastern Texas: identification of the rice rat, Oryzomys palustris, as reservoir host. Emerg Infect Dis. 1998;4:105–11.
- Fulhorst CF, Bennett SG, Milazzo ML, Murray HL, Webb JP Jr, Bradley RD. Bear Canyon virus: an arenavirus naturally associated with Peromyscus californicus (California mouse). Emerg Infect Dis. 2002;8:717–20.
- Fulhorst CF, Bowen MD, Ksiazek TG, Rollin PE, Nichol ST, Kosoy MY, Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology. 1996;224:114–20.
- Duchin JS, Koster FT, Peters CJ, Simpson G, Tempest B, Zaki S. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med. 1994;330:949–55.
- Huang C, Campbell WP, Means R, Ackman DM. Hantavirus S RNA sequence from a fatal case of HPS in New York. J Med Virol. 1996;50:5–8.
- Rhodes LV III, Huang C, Sanchez AJ, Nichol ST, Zaki SR, Ksiazek TG, Hantavirus pulmonary syndrome associated with Monongahela virus, Pennsylvania. Emerg Infect Dis. 2000;6:616–21.
- Abbott KD, Milazzo ML, Keith J, Bradley RD, Fulhorst CF. Epizootiology of arenavirus infections in the white-throated woodrat (Muridae: Sigmodontinae) and other woodrats in Arizona. J Vector Ecol. 2004;29:355–64.
- Bennett SG, Milazzo ML, Webb JP Jr, Fulhorst CF. Arenavirus antibody in rodents indigenous to coastal southern California. Am J Trop Med Hyg. 2000;62:626–30.
- Calisher CH, Nabity S, Root JJ, Fulhorst CF, Beaty BJ. Transmission of an arenavirus in white-throated woodrats (Neotoma albigula) in southeastern Colorado, 1995–1999. Emerg Infect Dis. 2001;7:397–402.
- Kosoy MY, Elliott LH, Ksiazek TG, Fulhorst CF, Rollin PE, Childs JE, Prevalence of antibodies to arenaviruses in rodents from the southern and western United States: evidence for an arenavirus associated with the genus Neotoma. Am J Trop Med Hyg. 1996;54:570–6.
- Fulhorst CF, Charrel RN, Weaver SC, Ksiazek TG, Bradley RD, Milazzo ML, Geographical distribution and genetic diversity of Whitewater Arroyo virus in the southwestern United States. Emerg Infect Dis. 2001;7:403–7.
- Ksiazek TG, Peters CJ, Rollin PE, Zaki S, Nichol S, Spiropoulou C, Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg. 1995;52:117–23.
- Vitek CR, Ksiazek TG, Peters CJ, Breiman RF. Evidence against infection with hantaviruses among forest and park workers in the southwestern United States. Clin Infect Dis. 1996;23:283–5.
- Zeitz PS, Graber JM, Voorhees RA, Kioski C, Shands LA, Ksiazek TG, Assessment of occupational risk for hantavirus infection in Arizona and New Mexico. J Occup Environ Med. 1997;39:463–7.
- Fritz CL, Fulhorst CF, Enge B, Winthrop KL, Glaser CA, Vugia DJ. Exposure to rodents and rodent-borne viruses among persons with elevated occupational risk. J Occup Environ Med. 2002;44:962–7.
- Park JY, Peters CJ, Rollin PE, Ksiazek TG, Katholi CR, Waites KB, Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: evidence of a decreased risk of infection. Am J Trop Med Hyg. 1997;57:37–41.
- Stephensen CB, Blount SR, Lanford RE, Holmes KV, Montali RJ, Fleenor ME, Prevalence of serum antibodies against lymphocytic choriomeningitis virus in selected populations from two US cities. J Med Virol. 1992;38:27–31.
- Childs JE, Glass GE, Korch GW, Ksiazek TG, LeDuc JW. Lymphocytic choriomeningitis virus infection and house mouse (Mus musculus) distribution in urban Baltimore. Am J Trop Med Hyg. 1992;47:27–34.
- Mills JN, Yates TL, Childs JE, Parmenter RR, Ksiazek TG, Rollin PE, Guidelines for working with rodents potentially infected with hantavirus. J Mammal. 1995;76:716–22.
- Centers for Disease Control and Prevention. Two cases of hantavirus pulmonary syndrome—Randolph County, West Virginia, July 2004. MMWR Morb Mortal Wkly Rep. 2004;53:1086–9.
- California Department of Health Services. Vector-borne disease section. Hantavirus pulmonary syndrome in California residents. 2004 Annual Report. Sacramento (CA): California Department of Health Services; 2005. p. 4–5.
- Canada Health and Welfare. First reported cases of hantavirus pulmonary syndrome in Canada. Can Commun Dis Rep. 1994;20:121–8.
- Jay M, Hjelle B, Davis R, Ascher M, Baylies HN, Reilly K, Occupational exposure leading to hantavirus pulmonary syndrome in a utility company employee. Clin Infect Dis. 1996;22:841–4.
- Fulhorst CF, Milazzo ML, Carroll DS, Charrel RN, Bradley RD. Natural host relationships and genetic diversity of Whitewater Arroyo virus in southern Texas. Am J Trop Med Hyg. 2002;67:114–8.
Suggested citation for this article: Fulhorst CF, Milazzo ML, Armstrong LR, Childs JE, Rollin PE, Khabbaz R, et al. Hantavirus and arenavirus antibodies in persons with occupational rodent exposure, North America. Emerg Infect Dis [serial on the Internet]. 2007 Apr [date cited]. Available from http://wwwnc.cdc.gov/eid/article/13/4/06-1509
- Page created: June 28, 2010
- Page last updated: June 28, 2010
- Page last reviewed: June 28, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)